Dec 29, 2020 | News, Regulatory
The U.S. Food and Drug Administration (FDA) has made their REMS requirements for transmucosal immediate-release fentanyl (TIRF) products more rigorous to minimize inappropriate prescriptions for the strong and highly addictive opioid. The REMS guidelines serve as a... 
Apr 17, 2020 | News, Regulatory
The FDA announced on Thursday (4/16) it was temporarily allowing compounding for necessary hospital drugs due to the mass shortage from COVID-19. The majority of the 13 commonly used drugs listed in the policy are anesthetic or analgesic drugs, which helps...
